Related by context. All words. (Click for frequent words.) 62 opioid naive 59 opioid dependent 58 VICTOR E1 58 severe hypoglycaemia 57 antiretroviral naive 56 vWD 56 blind placebo 56 IMPACT DCM trial 56 treatment naive genotype 56 dose escalation phase 55 excessive sleepiness 55 PREZISTA r 55 macular edema secondary 55 antiarrhythmic drug 55 transient insomnia 55 pulmonary hypertension PH 54 adjunctive ABILIFY 54 dirucotide MBP# 54 T1DM 54 OSAHS 54 Recurrent Glioblastoma 54 intravenous RSD# 54 obstructive sleep apnea hypopnea 54 Excessive daytime sleepiness 54 generalized anxiety disorder GAD 54 unresectable recurrent 53 PSVT 53 Primary endpoints 53 SSRI SNRI 53 de novo kidney transplant 53 ziconotide 53 randomized #:#:# 53 IBS C 53 weekly subcutaneous injections 53 recurrent seizures 53 circadian rhythm sleep 53 blinded placebo controlled 53 generalized tonic clonic seizures 53 Testosterone deficiency 53 juvenile myoclonic epilepsy 53 dually eligible 53 cognitively intact 53 EXJADE 52 mild renal insufficiency 52 CRVO 52 GH deficiency 52 Ulcerative colitis 52 C1 INH deficiency 52 Psychosocial interventions 52 evaluable subjects 52 Major Depressive Disorder 52 Major Depressive Disorder MDD 52 periodically reassessed 52 Migraine headache 52 Restless Legs Syndrome RLS 52 underwent liver transplantation 52 psychiatric comorbidities 52 nonepileptic seizures 52 dopaminergic therapy 52 RRMS patients 52 corticosteroid therapy 52 relapsing multiple sclerosis 52 FSAD 52 blinded randomized placebo controlled 52 metastatic dermatofibrosarcoma protuberans DFSP 52 symptomatic BPH 52 ramelteon 52 immunocompetent 52 nonpsychiatric 52 generalized seizures 52 Hypoactive Sexual Desire Disorder 52 convulsive seizures 52 reflux symptoms 52 randomized #:# 52 efalizumab 52 impaired renal 52 gastrointestinal adverse reactions 51 severe hepatic insufficiency 51 L PPDS 51 postoperative AF 51 comorbid disorders 51 fasting triglyceride levels 51 psychostimulants 51 proliferative diabetic retinopathy 51 IV tPA 51 severe exacerbations 51 lupus nephritis 51 menopausal symptom 51 fibromyalgia syndrome 51 lipid lowering medications 51 androgen excess 51 Major depressive disorder 51 schizophrenia schizoaffective disorder 51 bacterial prostatitis 51 akinetic mutism 51 Heavy menstrual bleeding 51 Etanercept 51 neuropsychological impairments 51 Lennox Gastaut syndrome 51 Depressive disorders 51 Clot busting 51 overactive bladder symptoms 51 retinal vein occlusion 51 Polypharmacy 51 proliferative retinopathy 51 levodopa induced 51 kidney insufficiency 51 defibrillator implantation 51 nonadherence 51 neovascular form 51 blinded placebo 51 tapentadol ER 51 Attention-Deficit/Hyperactivity Disorder ADHD 51 dilated cardiomyopathy DCM 51 ZOSTAVAX 51 premenstrual dysphoric disorder 51 sedating antihistamines 50 overactive bladder OAB 50 juvenile idiopathic arthritis 50 Systemic lupus 50 Hemophilia B 50 choroidal vasculopathy 50 habitual snoring 50 controlled dose escalation 50 symptom flare ups 50 HIV uninfected 50 secondary hypogonadism 50 unexplained syncope 50 adverse cytogenetics 50 glucocorticoid therapy 50 Nocturia 50 narcolepsy cataplexy 50 poststroke depression 50 LHON 50 unruptured aneurysm 50 Muscle relaxants 50 neurocognitive functioning 50 Treatment IND 50 ropinirole 50 unstable angina UA 50 NATRECOR R 50 nondepressed 50 status epilepticus 50 AIR CF1 50 impaired hepatic 50 sexual arousal disorder 50 psychoactive medication 50 daytime drowsiness 50 primary immunodeficiency PI 50 neurocognitive impairment 50 corticosteroid dose 50 familial hypercholesterolemia 50 refractory angina 50 Zaleplon 50 congenital deficiency 50 retinal vein occlusion induced 50 systolic hypertension 50 Pneumococcal vaccination 50 cirrhotic 50 Bronchiectasis 50 SHPT 50 hypoactive 50 dosing cohort 50 initiate Phase IIa 50 Peripheral neuropathy 50 psychotherapeutic drugs 50 severe obstructive sleep 50 CHAMPVA 50 somnolence dizziness 50 heavily pretreated 50 doxepin HCl 50 decompensated heart failure 50 Exacerbations 50 paroxysmal atrial fibrillation 50 Severe Primary IGFD 50 tardive dyskinesia TD 50 TYSABRI therapy 49 VAPRISOL 49 aged ≥ 49 Obstructive sleep apnea OSA 49 #q# deletion syndrome 49 overnight polysomnography 49 suboptimally 49 ICD shocks 49 Postherpetic neuralgia 49 anterior uveitis 49 chronic noncancer pain 49 nonischemic 49 extrapyramidal disorder 49 Myasthenia gravis 49 sulfite sensitive 49 diabetic retinopathy DR 49 daytime alertness 49 schizophrenia CIAS 49 ALT elevations 49 elevated IOP 49 LibiGel Phase III 49 gemifloxacin 49 Essential Tremor 49 PsA 49 Bedwetting 49 hyper IgE syndrome 49 T2DM 49 upper limb spasticity 49 constipation predominant irritable bowel 49 PONV 49 Irritable bowel syndrome 49 HCV infected 49 dysfunctional voiding 49 acutely unwell 49 RLS symptoms 49 affective psychoses 49 Neuropathic pain 49 oral sapacitabine 49 CIPN 49 chronic neurological disorder 49 hemiplegic 49 achieved sustained virological 49 receiving TEMODAR 49 diabetic kidney 49 Raynaud syndrome 49 Neovascular AMD 49 Dual eligibles 49 epilepsy 49 progressive MS SPMS 49 PULMICORT RESPULES 49 HSDD 49 zaleplon 49 ULTRAM ER 49 treat narcolepsy 49 MADIT II 49 apnea sufferers 49 metastatic CRPC 49 Drowsiness 49 immune suppressive 49 oral anticoagulation 49 airflow limitation 49 bronchial hyperresponsiveness 49 fistulizing CD 49 tic disorder 49 Anti psychotics 49 prospective randomized placebo 49 nontraumatic 49 untreated OSA 49 exocrine pancreatic insufficiency 49 TMS Therapy 49 Generalized anxiety disorder 49 Oppositional Defiant Disorder 48 hypoglycemic episodes 48 MoxDuo 48 arterial thromboembolic events 48 hypersomnia 48 macroalbuminuria 48 ATACAND 48 Placebo controlled 48 orthostatic hypotension 48 neuropsychological functioning 48 isolated systolic hypertension 48 mu opioid agonists 48 PLMS 48 confusional 48 atrioventricular block 48 FLT3 mutations 48 Rheumatoid Arthritis RA 48 Temporal lobe epilepsy 48 Acute Decompensated Heart Failure 48 TF CBT 48 Provent Therapy 48 heterozygous FH 48 poststroke 48 ADHF 48 warfarin therapy 48 persistent muscle spasms 48 Posttraumatic stress disorder PTSD 48 painful diabetic peripheral 48 euthyroid 48 Acute myeloid leukemia 48 fat malabsorption 48 enuresis 48 primary axillary hyperhidrosis 48 pharmacological therapy 48 vulvar pain 48 psychoactive medications 48 Bone marrow transplant 48 atrial tachyarrhythmias 48 hypochondriasis 48 sleep disorder narcolepsy 48 transaminase elevations 48 immunocompromised 48 Growth hormone deficiency 48 Natalizumab 48 dysthymic 48 nighttime awakenings 48 tetraplegia 48 traumatic spinal cord 48 Gestational diabetes 48 dermatologic reactions 48 variceal bleeding 48 Teagan intubated 48 rapid virologic response 48 Overactive bladder 48 controlled multicenter 48 insomnia sufferers 48 Phase #b/#a trial 48 concurrent ITP 48 juvenile idiopathic arthritis JIA 48 impaired cognition 48 OAB symptoms 48 budesonide MMX Phase III 48 Vitamin B# deficiency 48 COPD exacerbation 48 lacosamide 48 opioid induced 48 Sexsomnia 48 RISPERDAL 48 prescribed statins 48 Pervasive Developmental Disorder 48 ocular adverse 48 postinjury 48 episodic migraine 48 opioid overdose 48 Pneumonia vaccine 48 Obstructive Sleep Apnea OSA 48 stellate ganglion block 48 rituximab refractory follicular 48 histologically confirmed 48 neurologic sequelae 48 asthma exacerbation 48 intermittent claudication 48 Aortic stenosis 48 PGY 48 Myelodysplastic syndromes 48 Corticosteroid 48 multiorgan 48 undergone splenectomy 48 REVIVE Diabetes 48 severe aortic stenosis 48 parkinsonian 48 unstable angina pectoris 48 diabetic macular edema 48 Systemic lupus erythematosus SLE 48 Comorbid 48 asthma exacerbations 48 tryptophan depletion 48 hyperprolactinemia 48 dually diagnosed 48 narcolepsy sleep apnea 48 intravitreal injections 48 ENGAGE AF TIMI 48 Bacterial conjunctivitis 48 HC APAP 48 Multicenter Randomized Double 48 receiving TNF blockers 48 Infantile spasms 47 milrinone 47 hypopnea syndrome 47 behavioral disturbances 47 Children 47 NNT = 47 CNS depressant 47 subclinical hypothyroidism 47 Prodarsan 47 active PsA 47 nonrandomized 47 nonpharmacological treatments 47 LillyAnswers 47 untreated sleep apnea 47 placebo controlled clinical 47 onset diabetes mellitus 47 common disabling neurological 47 prescribe Paxil 47 Hepatotoxicity 47 diagnosed Ph + 47 Substance misuse 47 Occupational therapists 47 symptom exacerbation 47 MELAS 47 Ankylosing spondylitis 47 optic neuropathy NAION 47 nonmetastatic prostate cancer 47 SRBD 47 recurrent VTE 47 conjunctival hyperemia 47 postpartum mood 47 comorbid conditions 47 Secondary endpoints include 47 Gastrointestinal bleeding 47 clinically heterogeneous 47 Migraine headaches 47 prescribed opioids 47 phase Ib 47 degenerative neurological diseases 47 Liver toxicity 47 Pramipexole 47 perioperative complications 47 AAT deficiency 47 anticholinergic medication 47 acute myocardial infarction AMI 47 cystic fibrosis chronic pancreatitis 47 androgen ablation therapy 47 intravitreal insert 47 RLS sufferers 47 limiting generalizability 47 untreated AML 47 antidepressant therapy 47 sustained ventricular tachycardia 47 nucleoside naive 47 diagnosable mental disorders 47 von Willebrand disease 47 asymptomatic PAD 47 erectile dysfunction impotence 47 Chronic Insomnia 47 Shingles vaccine 47 renal flares 47 rhGH 47 undetectable HBV DNA 47 Acute Coronary Syndromes ACS 47 nocturnal awakenings 47 ventricular tachycardia VT 47 atherothrombosis 47 cataplexy 47 Acute Stress Disorder 47 neuropsychiatric symptoms 47 related hematological toxicity 47 chronic periodontitis 47 disordered breathing 47 methylphenidate Ritalin 47 vaginal atrophy 47 acute myelogenous leukemia AML 47 #mg ATC 47 uncontrolled seizures 47 AIOD 47 discoid lupus 47 NYHA Class II 47 deCODE Glaucoma TM 47 evaluable 47 comorbid anxiety 47 anticholinergic effects 47 chloride secretion 47 decrements 47 Fuchs dystrophy 47 symptomatically stable 47 Allovectin 7 ® 47 valvular disease 47 Sleep disordered breathing 47 Daytime sleepiness 47 Obstructive Sleep Apnea 47 posttraumatic stress disorder PTSD 47 Depressed bipolar 47 aromatase inhibitor therapy 47 occlusion CRVO 47 hypotensive 47 paroxysmal AF 47 GH deficient 47 Chronic Migraine 47 post tramatic stress 47 class mGluR5 inhibitor 47 vulvodynia 47 regorafenib 47 hyperactive impulsive 47 lumbar degenerative 47 Researchers randomly assigned 47 fatal anaphylactic 47 CINV 47 ruboxistaurin 47 label dose escalation 47 Chronic cough 47 multicenter randomized placebo controlled 47 Oral mucositis 47 premorbid 47 CHAMPION PCI 47 amblyopic 47 atomoxetine 47 hypopneas 47 neuropathic 47 pegaptanib 47 neovascular glaucoma 47 polyarticular 47 mood dysregulation 47 CPAP adherence 47 Aggrenox ® 47 somatostatin analogs 47 recurrent wheezing 47 prescribed antipsychotics 47 COSIRA trial 47 GnRH agonists 47 severely active polyarticular 47 Merck KGaA Rebif 47 dyslipidaemia 47 rheumatological 47 UPPP 47 wide receiver Kenbrell Thompkins 47 medically refractory 46 CTEPH 46 benign prostatic hypertrophy BPH 46 antiseizure drug 46 phosphodiesterase inhibitors 46 Cataplexy 46 dyskinesia 46 malabsorptive 46 Hill Rom enhancing 46 dyspareunia 46 nonobese 46 psoriatic arthritis PsA 46 NPM1 mutation 46 Acute Myeloid Leukaemia AML 46 Severe Asthma 46 Anaphylactic shock 46 dose cohorts 46 Lupus nephritis 46 intractable epilepsy 46 vasomotor symptoms 46 significant cytopenia 46 IPF CAPACITY 46 apneic episodes 46 neurobehavioral disorder 46 Meniere disease 46 TMJD 46 dosing cohorts 46 Obstructive Sleep Apnoea 46 untreated obstructive sleep 46 schizophrenia bipolar disorders 46 underwent CABG 46 untreated celiac disease 46 Impaired Glucose Tolerance 46 pegnivacogin 46 Vernakalant oral 46 hypoglycemia unawareness 46 Rheumatoid arthritis RA 46 dextofisopam 46 Bronchial thermoplasty 46 Polysomnographic 46 idiopathic Parkinson disease 46 neurocognitive deficits 46 Callisto initiated 46 inhaled tobramycin 46 ABSTRAL 46 ischemic cardiomyopathy 46 chronic rheumatic 46 Pathological gambling 46 Female Sexual Dysfunction 46 blind multicenter 46 Venous thromboembolism 46 traumatic amputations 46 renal scarring 46 sedative hypnotics 46 intrinsic sphincter deficiency 46 phase IIb trial 46 Chronic sinusitis 46 progranulin mutations 46 antiphospholipid syndrome 46 Postherpetic neuralgia PHN 46 ofpatients 46 NOMID 46 obstructive sleep 46 glycated hemoglobin levels 46 Gorlin syndrome 46 chronic thromboembolic pulmonary 46 seizure disorders 46 immuno compromised patients 46 BRIM3 46 Dose escalation 46 Idiopathic pulmonary fibrosis IPF 46 Chronic insomnia 46 neovascular 46 hyperkalemia 46 randomized Phase IIb 46 Dr Al Jishi 46 unfavorable prognostic 46 anorexia nervosa bulimia nervosa 46 attention-deficit/hyperactivity disorder ADHD 46 hypoxemia 46 Obsessive compulsive disorder 46 spinal scoliosis 46 stimulant medications 46 Afib 46 choroidal neovascularization 46 chronic migraine headaches 46 atopic disorders 46 immuno suppressed 46 dosed intravenously 46 acute psychosis 46 CUPID trial 46 prior chemotherapy regimens 46 extrapyramidal symptoms 46 Al-Anon/Alateen meetings 46 Endarterectomy 46 dysmenorrhea 46 decompensated 46 HBV infected 46 Wet AMD 46 Spinal manipulation 46 chronic hepatitis cirrhosis 46 dose dose escalation 46 subclinical disease 46 REM sleep behavior 46 normotensive 46 therapeutically beneficial 46 fatal myelination disorder 46 Acute sinusitis 46 immunocompromised patients 46 gastroenterology neurology 46 apneic 46 mentally disordered 46 hematological malignancy 46 diabetes mellitus DM 46 Chronic constipation 46 idiopathic scoliosis 46 heartburn ulcers 46 Eisenmenger syndrome 46 Acute pancreatitis 46 Lactose intolerance 46 prospective randomized multicenter 46 primary aldosteronism 46 syncope 46 DBMD 46 frequent awakenings 46 GERD symptoms 46 blepharospasm 46 beta blocker therapy 46 Chronic Sinusitis 46 Hypogonadism 46 pancreas secretes insulin 46 Obstructive sleep apnea 46 Treatment Experienced 46 severe Primary IGFD 46 anticholinergics 46 primary dysmenorrhoea 46 concomitant cardiac 46 chronic myocardial ischemia 46 Ballot tabulation 45 underwent angiography 45 Prehypertension 45 anticholinergic medications 45 lumbar disc disease 45 systolic dysfunction 45 AAT Deficiency 45 severely emotionally disturbed 45 decompensated cirrhosis 45 somatoform disorders 45 constipation nausea 45 gastro esophageal reflux 45 BRANCH Smart 45 nonarteritic anterior ischemic optic 45 Overactive Bladder 45 RESIST studies 45 thyroid deficiency 45 Pamelor 45 Irritable bowel syndrome IBS 45 SomatoKine 45 left ventricular dysfunction 45 lumbar spinal stenosis LSS 45 squamous cell lung cancer 45 randomized controlled multicenter 45 phase IIb clinical 45 Knee osteoarthritis 45 Provigil modafinil 45 receiving antiretroviral therapy 45 habilitative 45 comorbid psychiatric 45 EBMT criteria 45 chronic insomnia 45 subjective sleepiness 45 azoospermia 45 hypothalamic amenorrhea 45 premenstrual syndrome PMS 45 loop diuretics 45 psychosocial functioning 45 Cladribine tablets 45 dysfunction LVSD 45 rALLy clinical trial 45 dorzolamide 45 headache nausea fatigue 45 stable angina 45 hydroxyurea therapy 45 Systemic Lupus Erythematosus SLE 45 PRECISE Trial 45 APEX PD 45 treatment naļve 45 Non inferiority 45 ski lls 45 schizoaffective disorder bipolar 45 Fatty Liver Disease 45 Cluster headaches 45 ADVEXIN clinical 45 obstructive apnea 45 Phase IIIb study 45 debilitating autoimmune 45 angiotensin converting enzyme inhibitors 45 monoclonal gammopathy 45 MAO inhibitors 45 postoperative infections 45 dopamine antagonists 45 InterStim Therapy 45 LHRH agonists 45 invasive fungal infection 45 Spasticity 45 PDIs 45 ABRAXANE therapy 45 Enlarged prostate 45 autoimmune thyroiditis 45 LQTS 45 NNRTI 45 psychosocial distress 45 upper gastrointestinal bleeding 45 moderate ulcerative colitis 45 neurobiological disorders 45 RSV infections 45 recurrent miscarriage 45 tachycardias 45 neovascular AMD 45 Sleepiness 45 bony metastases 45 hypoventilation 45 Chronic Heart Failure 45 severely immunocompromised patients 45 Stress urinary incontinence 45 immunosuppressed patients 45 underwent percutaneous coronary 45 depressive symptomatology 45 somatostatin analog 45 myoclonus 45 http:/www.clinicaltrials.gov 45 DVT PE 45 multicentre prospective 45 parkinson disease 45 multicentre randomized double 45 disc herniations 45 seroconverted 45 akathisia 45 Cervical dystonia 45 LHRH antagonists 45 Reye syndrome rare 45 confusion disorientation 45 thromboembolic events 45 primary dysmenorrhea 45 primary immunodeficiency 45 Prostate enlargement 45 lorazepam Ativan 45 ROCKET AF 45 Constipation IBS C 45 EoE 45 Chronic fatigue 45 traumatic disabling neurological 45 sedatives hypnotics 45 neuropsychiatric disorder 45 OPT CHF 45 uncorrected vision 45 MDD 45 intracranial hypertension 45 pain palliation 45 cardioverted 45 insomnia sleep apnea 45 COPD exacerbations 45 cirrhotic patients 45 Socioeconomic factors 45 PEER SUPPORT 45 randomized multicenter 45 Childhood Disorder 45 abnormal clotting 45 Soft Tissue Sarcoma 45 Chronic pelvic 45 manic episode 45 APPRISE 45 prescribed antipsychotic 45 Menactra vaccine 45 leptin resistant 45 ADHD meds 45 hyperpyrexia 45 hypoglycaemic unawareness 45 symptomatic aortic stenosis 45 Ventricular Tachycardia 45 Attention Deficit Hyperactive Disorder 45 antithrombotic therapy 45 atopic 45 NSTEMI 45 Anxiety disorders 45 hyperlipidaemia 45 unstable angina chest 45 benign prostatic hypertrophy 45 radicular pain 45 aortic valve stenosis 45 severe obstructive pulmonary 45 nadroparin 45 Sleep disturbances 45 inherited retinal degeneration 45 Urinary incontinence affects 45 undergoing coronary angiography 45 myofascial pain 45 EEG abnormalities 45 testosterone deficiency 45 FEDVIP 45 dizziness headache nausea 45 vulvovaginal atrophy 44 Economically disadvantaged 44 treatment naïve genotype 44 sinus node dysfunction 44 confusional arousals 44 prostate cancer CaP 44 masked placebo controlled 44 inpatient hospitalization 44 progressive neurodegenerative disorder 44 BPS IC 44 pulmonary artery hypertension 44 paclitaxel eluting stents 44 Disordered eating 44 Postcode lottery 44 β blockers 44 Premature ejaculation 44 renal allograft 44 cerebral oxygenation 44 deafness blindness 44 AIMM trial 44 GATTEX therapy 44 neuromuscular spasm 44 Acute renal failure 44 chronic neuropathic pain 44 arterial thrombosis 44 Sexual arousal 44 relapsed myeloma 44 Fecal incontinence 44 dysthymic disorder 44 myeloproliferative neoplasms 44 amnestic MCI 44 muscular spasticity 44 upper airway obstruction 44 Acute Coronary Syndrome 44 cirrhosis liver failure 44 Acute leukemia 44 fatal neurodegenerative disorders 44 nocturia 44 microscopic hematuria 44 successfully commercialize Iluvien 44 neurologic dysfunction 44 Xanax alprazolam 44 immunodeficient 44 sensory neuropathy 44 ototoxic 44 cognitively impaired 44 flush apalooza 44 Prostatitis 44 psychiatrically ill 44 Pneumococcal pneumonia 44 MIST II 44 disabling neurological condition 44 Dysmenorrhea 44 pre exisiting 44 nonambulatory 44 patellofemoral pain syndrome 44 sympathomimetic amines 44 neoplastic diseases 44 recidivate 44 PAOD 44 androgen deficiency 44 Pausch blogged regularly 44 Marci Shatzman writes 44 hormones ghrelin 44 HbA1c levels 44 psychotropic medicines 44 Phase IIIb clinical 44 VCFS 44 musculoskeletal pain 44 thrombotic complications 44 chronically mentally ill 44 adenotonsillectomy 44 mild gestational diabetes 44 dysplastic lesions 44 pegylated interferon peg IFN 44 WIA eligibility 44 Celiac disease affects 44 headache flushing 44 Latent TB 44 pretreatment serum 44 intravitreal triamcinolone 44 myotonia 44 neurologic disorder 44 vitreous hemorrhage 44 Fluid retention 44 chronic urticaria 44 Influenza vaccination 44 somatic symptoms 44 daily subcutaneous injections 44 NCQA Accredited 44 prucalopride 44 impaired glucose tolerance 44 untreated ADHD 44 angina pectoris 44 T1D 44 Phase 2a trial 44 Fluzone Intradermal vaccine 44 denosumab oncology clinical trials 44 macular degeneration glaucoma 44 premenstrual dysphoric disorder PMDD 44 chemically dependent 44 Sumatriptan OS 44 Pulmonary arterial hypertension 44 immuno compromised 44 idiopathic epilepsy 44 fibromyalgia arthritis 44 AERIUS 44 Pharmacologic 44 Phase III randomized 44 ABSORB trial 44 CP CPPS 44 genotype 1a 44 Ranolazine 44 MADIT 44 Mental retardation 44 Nonspecific 44 narrowed carotid arteries 44 Cognitive impairment 44 Methadone Maintenance 44 Psychiatric disorders 44 unmedicated 44 Chickenpox vaccine 44 severe hypoglycemia 44 myasthenia gravis MG 44 AIR2 Trial 44 intrathecal baclofen 44 perfusion abnormalities 44 refractory prostate cancer 44 dysmorphic 44 schizophrenic bipolar 44 debilitating complication 44 glaucoma cataracts 44 LSCD 44 Arrhythmias 44 Nothing Wadden 44 delirium convulsions 44 Phase III HEAT 44 O PPDS 44 sedating antihistamine 44 Secondhand smoke exposure 44 ALDH2 deficient 44 commercialize ZYFLO CR 44 hyperreflexia 44 ATV RiderCourse SM 44 brompheniramine 44 neuromuscular dysfunction 44 motor neuron diseases 44 neurocognitive function 44 TNF blocker therapy 44 Socially disadvantaged 44 cardiac repolarization 44 opiate dependency 44 tricyclics 44 Pneumococcal vaccines 44 anti convulsants 44 non sedating antihistamine 44 separated divorced widowed 44 nephrotoxicity 44 placebo controlled randomized 44 Anti VEGF 44 CMV seropositive 44 intermittent exotropia 44 Peripheral artery disease 44 opioid misuse 44 initiate Phase 1b 44 STAT3 signaling 44 neuroinflammatory 44 bladder dysfunction 44 multi infarct dementia 44 neuropsychological impairment 44 dial +#-#-#-# [003] 44 asthma bronchitis emphysema 44 CFTR corrector 44 circadian misalignment 44 CLIRS trial 44 nephrology oncology 44 anti convulsant drugs 44 afib 44 ximelagatran 44 TEVAR 44 adenoidectomy 44 bronchial thermoplasty 44 blinded randomized controlled 44 vestibular rehabilitation 44 ADEs 44 Diabetic neuropathy 44 thyroiditis 44 post thrombotic syndrome 44 ischemic stroke 44 tonsillar hypertrophy 44 irreversible blindness 44 Chronically ill 44 atherothrombotic 44 Escitalopram 44 Medicare EHR Incentive 44 Iron deficiency anemia 44 tachyarrhythmias 44 parasomnias 44 myeloproliferative 44 multicenter multinational 44 undergoing radical prostatectomy 44 Multicenter Automatic Defibrillator Implantation 44 oral ridaforolimus 44 thromboembolic 44 prescribed antipsychotic medication 44 Imipramine